Miao Miao Selected Research

hetrombopag

1/2022

A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miao Miao Research Topics

Disease

15	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 10/2009
11	Neoplasms (Cancer) 01/2022 - 01/2014
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2020 - 03/2006
10	Infections 02/2022 - 03/2008
10	Leukemia 01/2021 - 08/2004
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2009
9	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 08/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 10/2013
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 01/2020
4	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2020
4	Multiple Myeloma 01/2022 - 01/2013
4	Disease Progression 01/2021 - 01/2013
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2017 - 03/2008
4	Hematologic Neoplasms (Hematological Malignancy) 01/2013 - 08/2004
3	Residual Neoplasm 01/2021 - 11/2011
2	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2020
2	Body Weight (Weight, Body) 01/2022 - 01/2021
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 12/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2021
2	Rheumatoid Arthritis 01/2022 - 10/2017
2	Arthritis (Polyarthritis) 01/2022 - 10/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 10/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 05/2009
2	COVID-19 12/2020 - 12/2020
2	Inflammation (Inflammations) 01/2020 - 10/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2018 - 05/2013
2	Dandruff 09/2017 - 10/2015
2	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 01/2011 - 09/2009
2	Lymphoid Leukemia 03/2008 - 03/2006
2	Hematologic Diseases (Blood Diseases) 08/2006 - 08/2003
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2022
1	Exanthema (Rash) 05/2022
1	Atherosclerosis 03/2022
1	Glucose Intolerance 01/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2022
1	Dysbiosis 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 06/2021
1	Rheumatic Diseases (Rheumatism) 06/2021
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Memory Disorders (Memory Loss) 01/2021

Drug/Important Bio-Agent (IBA)

9	Interleukin-2 (IL2)IBA 05/2022 - 01/2020
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2014 - 08/2003
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2018
4	Long Noncoding RNAIBA 03/2022 - 10/2017
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 02/2008
4	Decitabine FDA Link 01/2020 - 10/2013
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 08/2004
3	Imatinib Mesylate (Gleevec)FDA Link 04/2017 - 03/2008
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2009 - 08/2003
2	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 03/2022 - 01/2021
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2022
2	Inulin FDA Link 01/2022 - 12/2021
2	AntioxidantsIBA 01/2022 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2017
2	Thrombopoietin (c-mpl Ligand)IBA 01/2022 - 05/2012
2	SteroidsIBA 06/2021 - 04/2012
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2013
2	AutoantibodiesIBA 01/2020 - 05/2013
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2020 - 01/2013
2	Monoclonal AntibodiesIBA 01/2020 - 02/2008
2	Rituximab (Mabthera)FDA Link 01/2020 - 04/2019
2	CytokinesIBA 10/2018 - 10/2017
2	GDC-0152IBA 08/2018 - 02/2015
2	Therapeutic UsesIBA 10/2017 - 01/2013
2	climbazoleIBA 09/2017 - 10/2015
2	pyrithione zinc (ZPT)FDA Link 09/2017 - 10/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2014 - 02/2008
2	Levofloxacin (Levaquin)FDA Link 01/2013 - 08/2004
2	Biological ProductsIBA 01/2011 - 01/2011
1	Azacitidine (5 Azacytidine)FDA Link 10/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	polysaccharide peptideIBA 03/2022
1	crustinIBA 02/2022
1	Antimicrobial PeptidesIBA 02/2022
1	InterleukinsIBA 01/2022
1	GlycolipidsIBA 01/2022
1	Fructans (Levans)IBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	hetrombopagIBA 01/2022
1	PrebioticsIBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	GlobulinsIBA 12/2021
1	GlucocorticoidsIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 03/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	CreatinineIBA 01/2021
1	AlbuminsIBA 01/2021

Therapy/Procedure

28	Hematopoietic Stem Cell Transplantation 12/2021 - 08/2004
16	Therapeutics 10/2022 - 08/2003
13	Transplantation 01/2022 - 03/2008
11	Drug Therapy (Chemotherapy) 06/2022 - 08/2004
10	Stem Cell Transplantation 01/2022 - 08/2003
2	Cell Transplantation 12/2021 - 03/2015
1	Immunotherapy 01/2021